Summary
Dragon Pharma’s Sustanon 350, a blend of injectable testosterone esters, was subjected to independent analysis to verify its composition and label claims. The sample, identified as batch number DPSUST-1809 with an expiration date of September 2021, was submitted by AnabolicLab.com for testing. The analysis was conducted by SIMEC AG, a well-regarded pharmaceutical testing laboratory, utilizing HPLC and microbiological methods.
The results confirmed that the product contained the labeled testosterone esters—Testosterone Enanthate, Testosterone Cypionate, and Testosterone Propionate. The concentrations were close to label claims, with slight variances observed in the measured results. The product was confirmed microbiologically safe, with no detectable contamination.
Detailed Report
Product Overview
- Manufacturer: Dragon Pharma
- Product Name: Sustanon 350
- Batch Number: DPSUST-1809
- Expiration Date: September 2021
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: C 88679
- Testing Ordered: August 29, 2019
- Sample Received: August 29, 2019
- Analysis Conducted By: SIMEC AG
- Product Submitted By: AnabolicLab.com
- Analysis Paid For By: AnabolicLab.com
Testing Results
| Testosterone Ester | Specification (Label Claim) | Measured Concentration | Accuracy | Variance |
|---|---|---|---|---|
| Testosterone Enanthate | 200 mg/ml | 219 mg/ml | 109.5% | +9.5% |
| Testosterone Cypionate | 100 mg/ml | 111 mg/ml | 111.0% | +11.0% |
| Testosterone Propionate | 50 mg/ml | 55 mg/ml | 110.0% | +10.0% |
| Microbiological Testing | Result | Specification |
|---|---|---|
| TAMC | Not Detectable/ml | Complies |
| TYMC | Not Detectable/ml | Complies |
Evaluation of Independent Testing
The analysis of Dragon Pharma’s Sustanon 350 demonstrated that the product met its label claims with minor positive variances in all three testosterone ester concentrations. The slight overdosage in the measured results falls within an acceptable range and does not compromise product quality. Microbiological analysis confirmed the product’s sterility, ensuring its safety for use.
These findings emphasize the importance of independent validation for ensuring product quality, consistency, and safety. Dragon Pharma’s Sustanon 350 performed well in this analysis, providing assurance to consumers about its authenticity and composition.
Conclusion
Dragon Pharma’s Sustanon 350 was found to be accurately formulated, with slight overages in its labeled testosterone esters and confirmed sterility. This independent analysis supports the product’s authenticity and manufacturing quality. Independent testing continues to play a vital role in promoting transparency and harm reduction in the anabolic steroid market.
Disclaimer
This report is published for educational and harm reduction purposes. Independent testing provides valuable insights; however, these findings pertain solely to the analyzed batch and may not represent the entire product line. Consumers are encouraged to critically assess this information alongside additional independent analyses to make informed decisions.
Discuss the Dragon Pharma Sustanon 350 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
